JPRN-jRCT1050220134
Recruiting
N/A
ong-term observational study for pediatric brain tumors - PBT-LTF
Fujisaki Hiroyuki0 sites1,000 target enrollmentDecember 15, 2022
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Pediatric brain tumor
- Sponsor
- Fujisaki Hiroyuki
- Enrollment
- 1000
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients with brain tumors younger than 30 years old at diagnosis (histology is not limited).
- •2\) Registration of the JCCG pediatric solid tumor observation study has been completed at the time of participation in this study.
- •3\) Registration for the other prospective interventional study for pediatric brain tumors conducted by JCCG is completed.
- •3\) At the same time as this study, the patient is enrolled or will be enrolled in a prospective clinical study conducted by the JCCG Brain Tumor Committee.
- •4\) Written informed consent from the patient and/or legally acceptable proxy has been obtained.
Exclusion Criteria
- •Patients who are unable to evaluate the late effects.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A prospective observational study in child patients with RSV infectioRSV infectionJPRN-jRCT1030230252Ishiwada Naruhiko100
Recruiting
N/A
The observation study in pediatric brain MR ImagesJPRN-UMIN000032927Chiba University Hospital60
Recruiting
N/A
Prospective observational study on child development born to mother with antiepileptic drugsEpilepsyJPRN-UMIN000038908ational Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders400
Completed
Phase 4
A prospective pediatric longitudinal evaluation to assess the long-term safety of tacrolimus ointment for the treatment of atopic dermatitis.Atopic Dermatitis10014982NL-OMON30879Astellas Pharma120
Withdrawn
N/A
Mucopolysaccharidosis Type II ObservationalMucopolysaccharidosis IINCT04591834REGENXBIO Inc.